Angiotensin Inhibition After Myocardial Infarction: Does Drug Class Matter?

BACKGROUND: Angiotensin converting enzyme-inhibitors (ACEI) and angiotensin-II-receptor blockers (ARB) are equally efficacious in reducing mortality after MI, although the latter are far more costly. Little is known about their relative use after MI in typical care settings, and about their relative...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Winkelmayer, Wolfgang C, Fischer, Michael A, Schneeweiss, Sebastian, Levin, Raisa, Avorn, Jerry
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2006
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1924742/
https://ncbi.nlm.nih.gov/pubmed/17105523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1525-1497.2006.00590.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi